Conmed (CNMD) EPS (Diluted) Growth (3y) (2013 - 2026)
Conmed (CNMD) EPS (Diluted) Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -6.43% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 7.66% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 3.09% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 62.91% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 63.42% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 30.57% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 29.56% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Conmed | 1.29 Bn | 1.26 Bn | 183.45 Mn | 97.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 97.87% |
| Dec 31, 2025 | -34.47% |
| Sep 30, 2025 | -60.41% |
| Jun 30, 2025 | 28.50% |
| Mar 31, 2025 | -23.09% |
| Dec 31, 2024 | 12.61% |
| Sep 30, 2024 | 50.16% |
| Jun 30, 2024 | 33.03% |
| Mar 31, 2024 | 26.11% |
| Dec 31, 2023 | -65.40% |
| Sep 30, 2023 | 29.00% |
| Jun 30, 2023 | 34.81% |
| Mar 31, 2023 | -33.64% |
| Dec 31, 2022 | 84.36% |
| Sep 30, 2022 | 85.10% |
| Jun 30, 2022 | -214.53% |
| Mar 31, 2022 | 129.66% |
| Dec 31, 2021 | 38.54% |
| Sep 30, 2021 | 32.43% |
| Jun 30, 2021 | 10.64% |